Neurometabolite changes in response to antidepressant medication: A systematic review of (1)H-MRS findings

Selective serotonin reuptake inhibitors (SSRIs), serotonin and noradrenaline reuptake inhibitors (SNRIs), and (es)ketamine are used to treat major depressive disorder (MDD). These different types of medication may involve common neural pathways related to glutamatergic and GABAergic neurotransmitter...

Descripción completa

Detalles Bibliográficos
Autores principales: Boucherie, Daphne E., Reneman, Liesbeth, Ruhé, Henricus G., Schrantee, Anouk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563053/
https://www.ncbi.nlm.nih.gov/pubmed/37812859
http://dx.doi.org/10.1016/j.nicl.2023.103517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563053/
https://www.ncbi.nlm.nih.gov/pubmed/37812859
http://dx.doi.org/10.1016/j.nicl.2023.103517

Ejemplares similares